Living Donor Kidney Transplantation From the Elderly Donor

Abstract

Purpose The organ shortage has led to increasing acceptance of living donation in all transplant centers. Although the risk of impaired long-term outcome seems to be greater using elderly donors, these organs are not generally refused for transplantation. We report our experience with 25 living donor kidney transplantations from donors older than 60 years. Methods Between 1995 and 2004, 124 living donor procedures were performed in our center from 83 related and 41 unrelated donors. Twenty-five donors (19 female, 6 male) were 60 years or older (mean, 65.3 ± 3.9 years). The recipient included (10 females and 15 males) showed a higher degree of variance in age (46.1 ± 14.6 years). The immunosuppressive protocol was cyclosporine (CyA)-based regimen in related cases and tacrolimus-based in unrelated cases. Results We transplanted 16 left and 9 right kidneys from older donors. The mean cold ischemia time was 171 ± 64 minutes with a second warm ischemia time of 24 ± 6 minutes. Severe arteriosclerosis made vascular reconstruction by graft interpostion necessary in two recipients. The acute rejection rate was 20%. Two patients (8%) required dialysis in the early postoperative course, whereas initial function was excellent in 22 patients (88%). The mean serum creatinine concentration after 12 months was 1.6 ± 0.3 mg/dL (n = 24) and 2.0 ± 0.7 mg/dL (n = 16) at 4 years. In comparison, the mean creatinine concentration after 4 years in donors under 60 years was 1.6 ± 0.9 mg/dL. Our analysis showed no significant difference in long-term graft function comparing young versus old donors in the setting of living donor transplants. Conclusion Using living donors older than 60 years for transplantation is a feasible and safe option. The difference in long-term creatinine between young and old donors was not significant.